#United States #Drug Safety #NABP #Mount Prospect #Pulse by NABP

NABP's New Pulse Platform for Dispensers

In a significant move towards improving drug supply chain safety, the National Association of Boards of Pharmacy (NABP) has introduced Pulse by NABP. This innovative platform empowers dispensers to create accounts that streamline the communication process within the drug supply chain, particularly in the face of growing concerns about counterfeit and substandard medications.

Purpose and Benefits of Pulse by NABP

Pulse is designed to enhance interoperability among various stakeholders in the pharmacy supply chain, making it easier for dispensers to comply with regulatory requirements. By simplifying the process of achieving compliance with the Drug Supply Chain Security Act (DSCSA), the NABP aims to protect patients from unsafe medications.

After launching the platform early in 2026, regulators have begun utilizing Pulse to identify questionable products in pharmacies. As of July 2026, several chain pharmacies are integrating into the system, with distributors set to join in the fall. "We are excited to expand the availability of Pulse by NABP to more members of the supply chain," remarked NABP Executive Director, Lemrey 'Al' Carter, PharmD, MS, RPh. This initiative reflects the NABP's ongoing commitment to patient safety—a core principle that drives the Association.

Tools and Features of Pulse

The Pulse platform offers dispensers and their trading partners a variety of user-friendly tools designed to build a more transparent and secure drug supply chain. Key features of the platform include:

• - Authorized Trading Partner Status: Through this feature, dispensers can quickly verify their trading partners' standing, ensuring all involved parties are legitimate and compliant.
• - Streamlined Communication: The platform allows users to share preferred contacts, which simplifies communication across the supply chain, enabling faster response times and enhanced collaboration.
• - Information Searches: Dispensers can perform searches for essential data, such as Global Location Numbers (GLNs) and state licenses, which further enhances the platform’s usability.
• - Secure Interactions: The platform promotes secure communications between trading partners, safeguarding sensitive information and reducing the risk of data breaches.

These functionalities not only support regulatory compliance but also enhance trust among various stakeholders in the drug supply chain. By utilizing Pulse, dispensers can interact with verified partners of all sizes efficiently, thus fostering a more robust supply chain environment.

Future Prospects

As the pharmaceutical landscape continues to evolve, the introduction of Pulse by NABP represents a proactive approach to addressing challenges relating to drug safety. With the ever-present threat of substandard drugs infiltrating the market, tools that strengthen verification and communication among supply chain members are critical.

To learn more about how the Pulse platform can aid dispensers in compliance with the DSCSA, interested parties are encouraged to visit www.pulse.pharmacy. This site provides comprehensive information about the availability of tools and resources designed to fortify the safety and integrity of the drug supply chain.

Conclusion

In summary, the launch of Pulse by NABP marks a significant step forward in ensuring the security and safety of the drug supply chain. By facilitating better communication and compliance through cutting-edge digital solutions, the NABP is set to enhance pharmaceutical practices while keeping patient welfare at the forefront of its mission.